ng-nitroarginine methyl ester has been researched along with Nasal Obstruction in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, M; Kohno, S; Mizutani, N; Nabe, T; Tanaka, Y | 1 |
Al Suleimani, YM; Dong, Y; Walker, MJ | 1 |
Fujii, M; Kohno, S; Mizutani, N; Nabe, T; Yoshino, S | 1 |
Chapnik, J; Cole, P; McClean, P; Roth, Y; Silkoff, PE; Zamel, N | 1 |
Carratù, L; Faraone, S; Maniscalco, M; Sofia, M | 1 |
Carratù, L; Higenbottam, T; Maniscalco, M; Sofia, M | 1 |
Imai, A; Kohno, S; Mizutani, N; Nabe, T; Sakurai, H; Takenaka, H | 1 |
2 trial(s) available for ng-nitroarginine methyl ester and Nasal Obstruction
Article | Year |
---|---|
Nasal nitric oxide does not control basal nasal patency or acute congestion following allergen challenge in allergic rhinitis.
Topics: Acute Disease; Administration, Intranasal; Adult; Allergens; Bronchodilator Agents; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Manometry; Nasal Obstruction; Nasal Provocation Tests; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rhinitis, Allergic, Seasonal; Time Factors; Vascular Patency | 1999 |
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.
Topics: Adult; Airway Resistance; Bradykinin; Double-Blind Method; Female; Humans; Male; Nasal Obstruction; Nasal Provocation Tests; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor | 2000 |
5 other study(ies) available for ng-nitroarginine methyl ester and Nasal Obstruction
Article | Year |
---|---|
Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Blood Vessels; Disease Models, Animal; Drug Synergism; Guinea Pigs; Leukotriene D4; Male; Models, Biological; Naphazoline; Nasal Mucosa; Nasal Obstruction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Pollen; Rhinitis, Allergic, Seasonal; Thromboxane A2 | 2006 |
Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs.
Topics: Acetates; Acute Disease; Animals; Cetirizine; Cyclopropanes; Dexamethasone; Disease Models, Animal; Guinea Pigs; Heparin; Histamine H1 Antagonists; Male; Nasal Obstruction; NG-Nitroarginine Methyl Ester; Ovalbumin; Pyrilamine; Quinolines; Rhinitis, Allergic, Seasonal; Sneezing; Sulfides | 2008 |
Involvement of peroxynitrite in pollen-induced nasal blockage in guinea pigs.
Topics: Administration, Intranasal; Allergens; Allopurinol; Analysis of Variance; Animals; Antioxidants; Azoles; Cryptomeria; Disease Models, Animal; Guinea Pigs; Isoindoles; Leukotriene D4; Male; Nasal Obstruction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organoselenium Compounds; Peroxynitrous Acid; Pollen; Rhinitis, Allergic, Seasonal; Xanthine Oxidase | 2008 |
Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis.
Topics: Administration, Intranasal; Adult; Airway Resistance; Allergens; Enzyme Inhibitors; Female; Humans; Male; Nasal Obstruction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rhinitis, Allergic, Perennial | 2001 |
Involvement of nitric oxide in pollen-induced biphasic nasal blockage in sensitised guinea pigs.
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Allergens; Animals; Arginine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Guinea Pigs; Injections, Intravenous; Lysine; Male; Naphazoline; Nasal Obstruction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pollen; Rhinitis, Allergic, Seasonal; Sneezing; Time Factors | 2001 |